Itopride
- Generic Name
- Itopride
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N2O4
- CAS Number
- 122898-67-3
- Unique Ingredient Identifier
- 81BMQ80QRL
- Background
Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.
- Indication
Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
- Associated Conditions
- Abdominal Pain, Anorexia, Dyspepsia, Functional Dyspepsia, Gastroenteritis, Nausea, Nausea and vomiting, Vomiting, Abdominal bloating, Pyrosis, Stomach discomfort
Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal
Phase 3
Completed
- Conditions
- Dyspepsia
- First Posted Date
- 2005-06-01
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 645
- Registration Number
- NCT00112190
- Locations
- 🇨🇦
AXCAN Pharma Inc., Mont St-Hilaire, Quebec, Canada
Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
Phase 3
Completed
- Conditions
- Dyspepsia
- First Posted Date
- 2005-05-17
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 300
- Registration Number
- NCT00110968
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath